Product Information

SELEGILINE HCL 5 MG TABLET is a generic product labeled by i3 Pharmaceuticals, LLC, priced at $0.9041 per EA under NDC 72319000602. Its NADAC has been published 240 times since Apr 20, 2022.

FDA first approved this application on Apr 1, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SELEGILINE HCL 5 MG TABLET

Selegiline Hydrochloride
$0.9041per EA

Strength

5 mg/1

NDC

72319000602

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SELEGILINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074672

FDA Approved

4/1/1997

TE Code

AB

On Market Since

12/15/2021

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors
Monoamine Oxidase Type B Inhibitor
Monoamine Oxidase-B Inhibitors

Price Statistics

The NADAC for SELEGILINE HCL 5 MG TABLET has been published 240 times since Apr 20, 2022, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9041 per EA
All-time high$1.0975 (Aug 10, 2022)
All-time low$0.6101 (Jul 17, 2024)
52-week high$0.9041
52-week low$0.6895
Median price$0.8099
Average price$0.8250
Largest weekly change+33.5% (May 17, 2023)
Weeks tracked240
Tracking sinceApr 20, 2022

Price History

1W

+12.0%

1M

+12.0%

3M

+14.1%

6M

+19.2%

1Y

+27.1%

3Y

+6.7%

5Y

N/A

All

-10.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 33%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SELEGILINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG TABLET, manufactured by i3 Pharmaceuticals, LLC, is $0.9041 per EA (NDC 72319000602), effective Nov 18, 2026.

How has the price of SELEGILINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG TABLET has declined 10.3%. It has been tracked across 240 weekly CMS publications since Apr 20, 2022.

What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG TABLET?

Since Apr 20, 2022, the NADAC for SELEGILINE HCL 5 MG TABLET has ranged from a low of $0.6101 (Jul 17, 2024) to a high of $1.0975 (Aug 10, 2022), with a median of $0.8099 per EA.

Are there cheaper alternatives to SELEGILINE HCL 5 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SELEGILINE HCL 5 MG TABLET, is $0.6101 per EA — about 33% below SELEGILINE HCL 5 MG TABLET.

Who manufactures SELEGILINE HCL 5 MG TABLET?

SELEGILINE HCL 5 MG TABLET (NDC 72319000602) is labeled by i3 Pharmaceuticals, LLC, and CMS classifies it as a generic product.